US NewsEnglish · 1 year ago

FDA’s review of MDMA for PTSD highlights study bias and safety concerns

arstechnica.com

0

cross-posted to:
science@beehaw.org

10

FDA’s review of MDMA for PTSD highlights study bias and safety concerns

arstechnica.com

US NewsEnglish · 1 year ago

0

cross-posted to:
science@beehaw.org

FDA advisors will meet June 4 to discuss and vote on the therapy's effectiveness.

cross-posted from: https://reddthat.com/post/19935197

You must log in or register to comment.

Chat